BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30082164)

  • 1. Sanctuary Testicular Bladder Cancer Metastasis 10 Years After Radical Cystectomy and Adjuvant Chemotherapy.
    Saemundsson Y; Simoulis A; Liedberg F
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1097-e1099. PubMed ID: 30082164
    [No Abstract]   [Full Text] [Related]  

  • 2. Testicular metastasis of transitional cell carcinoma of the urinary bladder: an unusual site.
    Thwaini A; Kaluba J; Shergill I; Kumar R; Lewi H
    Int J Urol; 2006 Aug; 13(8):1136-7. PubMed ID: 16903948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Testicular metastasis from transitional cell carcinoma of the bladder].
    Negelev S; Paz A; Segal M
    Harefuah; 1995 Jan; 128(2):90-1, 127. PubMed ID: 7721183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid testicular metastasis from bladder transitional urothelial carcinoma after radical cystoprostatectomy: A case report.
    Wu K; Fan J; Liang H; Yao Y; He D
    Medicine (Baltimore); 2019 Nov; 98(48):e18000. PubMed ID: 31770212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronous solitary metastasis of transitional cell carcinoma of the bladder to the testis.
    Morgan K; Srinivas S; Freiha F
    Urology; 2004 Oct; 64(4):808-9. PubMed ID: 15491734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pelvic recurrence of urothelial tumor, after radical cysto-prostatectomy with orthotopic neo-bladder].
    Pascual Regueiro D; Mallén Mateo E; Trívez Boned MA; García García MA; Gil Sanz MJ; Rioja Sanz LA
    Actas Urol Esp; 2003 Sep; 27(8):629-32. PubMed ID: 14587238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder.
    Kaushik D; Frank I; Boorjian SA; Cheville JC; Eisenberg MS; Thapa P; Tarrell RF; Thompson RH
    Int J Urol; 2015 Jun; 22(6):549-54. PubMed ID: 25761779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [pT1G3 bladder carcinoma: parameters of a correct therapy].
    Ruoppolo M; Dell'Orto P; Fenice O; Seveso M; Ferri P; Zaatar C; Tagliaferri A; Cogni M; Bellorofonte G; Tombolini P
    Arch Ital Urol Androl; 1996 Feb; 68(1):17-20. PubMed ID: 8664914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nested variant of bladder transitional cell carcinoma: Review of 12 cases and review of the literature.
    Carrion-Ballardo CJ; Gala-Solana L; Portillo-Martin JA; Azueta-Etxebarria A; Truan-Cacho D; Campos-Juanatey F
    Actas Urol Esp; 2015; 39(6):387-91. PubMed ID: 25670479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
    Soave A; John LM; Dahlem R; Minner S; Engel O; Schmidt S; Kluth LA; Fisch M; Rink M
    Urology; 2015 Jul; 86(1):92-8. PubMed ID: 26051839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Testicular metastasis of transitional cell carcinoma of the prostate].
    Frens P
    Acta Urol Belg; 1998 Oct; 66(3):27-8. PubMed ID: 9864875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: patterns of initial transitional cell recurrence in patients after cystectomy.
    Zaghloul MS
    J Urol; 2007 Aug; 178(2):730; author reply 730. PubMed ID: 17574607
    [No Abstract]   [Full Text] [Related]  

  • 16. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Frazier HA; Robertson JE; Dodge RK; Paulson DF
    Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H
    Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy and follow-up of bladder cancer].
    Meyer D; Schmid HP; Engeler DS
    Wien Med Wochenschr; 2007; 157(7-8):162-9. PubMed ID: 17492413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
    Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF
    J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.